Relationship between contrast-induced nephropathy and long-term mortality after percutaneous coronary intervention in

Tuncay Güzel1, Adem Aktan2, Muhammed Demir3

  • 1Diyarbakir Gazi Yaşargil Training and Research Hospital, Department of Cardiology - Diyarbakır, Turkey.

Revista Da Associacao Medica Brasileira (1992)
|August 24, 2022
PubMed

Insights

Contrast-induced nephropathy after coronary angiography for chronic total occlusion significantly increases long-term mortality. Prophylactic measures and close patient monitoring are recommended to reduce adverse events.

Area of Science:

  • Cardiology
  • Nephrology
  • Interventional Cardiology

Background:

  • Chronic total occlusion (CTO) interventions are complex, requiring prolonged procedures and significant contrast dye.
  • Contrast-induced nephropathy (CIN) is a known complication of angiography, potentially impacting patient outcomes.

Purpose of the Study:

  • To investigate the association between contrast-induced nephropathy and long-term mortality in patients undergoing coronary angiography for CTO lesions.

Main Methods:

  • A cohort of 218 patients with CTO lesions from three centers underwent procedural coronary angiography.
  • Patients were stratified into groups based on CIN development.
  • All-cause mortality was tracked over a 100-month follow-up period.

Main Results:

  • Patients who developed CIN had a significantly higher long-term mortality rate (57.1% vs. 42.9%, p<0.001).
  • Kaplan-Meier analysis revealed shorter survival in the CIN group.
  • Logistic regression identified CIN as an independent predictor of mortality (OR 11.78).

Conclusions:

  • Contrast-induced nephropathy is significantly associated with increased long-term mortality in CTO patients.
  • Prophylactic strategies and vigilant post-procedure follow-up may mitigate adverse events.
Abstract

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
140
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
21
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
39
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
24
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
55